Author | Brian Miller, MD, PhD, MPH


Cognition and Outcomes in Clinical High-Risk for Psychosis

September 16, 2020

Does cognition predict outcomes in patients at clinical high-risk for psychosis?

What's In Your Mouth?

September 14, 2020

The role of the oropharyngeal microbiome in schizophrenia and mania.

Combination Therapy for Treatment-Resistant Schizophrenia?

September 04, 2020

New research on the role of adjunctive long-acting injectable antipsychotics in treatment-resistant schizophrenia.

Schizophrenia: Clinical Considerations in Men Versus Women

August 27, 2020

A nationwide cohort study sought to determine the clinical course of schizophrenia in women and men in order to improve diagnostic accuracy and design guidelines.

To Scan or Not to Scan: Brain Imaging in First-Episode Psychosis

August 25, 2020

The role of neuroimaging is to rule out medically or surgically treatable causes of illness, such as new-onset psychosis.

Understanding Comorbid Insomnia and Alcohol Use

August 07, 2020

Clinical considerations for evaluating treatment options for patients with insomnia and AUD versus patients with primary insomnia without substance use comorbidity.

Novel Insights on Cannabis and Psychosis

July 28, 2020

There is evidence in both patients with psychotic disorders and the general population that cannabis use is associated with adverse effects of psychopathology and cognition.

Autoimmune Psychosis?

July 13, 2020

New research on the prevalence of NMDA-receptor antibody encephalitis in first-episode and treatment-resistant psychosis

Does Insomnia Predict the Onset of Mental Illness?

July 11, 2020

Because insomnia is a syndrome marked by chronic sleep onset and/or continuity problems associated with impaired daytime functioning, it is important that clinicians screen for sleep issues in their patients.

Lowering Prolactin Levels in Patients With Psychosis

July 10, 2020

Treatment strategies for antipsychotic-induced hyperprolactinemia.